Remibrutinib shows promise in treating generalized myasthenia gravis, with ongoing trials assessing its efficacy and safety for patients.
Louie Pasculli
Advertisement
Articles by Louie Pasculli
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Most Favored Nation Drug Pricing Moves Forward, but Experts Warn Details Are Still Missing
2
Explore the Clinical Data for JOURNAVX® (suzetrigine)
3
Oncology Landscape Continues to Evolve With Expanded Indications, First-in-Class Therapies
4
FDA Approves Lumateperone as Add-On Therapy for Major Depressive Disorder
5
